54th AAPM: Physicists Keen on Superficial Radiotherapy for Non-Melanoma Skin Cancer

Once again, the Xstrahl team has participated in another successful annual American Association of Physicists in Medicine (AAPM) exhibition in Charlotte, July 29th to August 2nd—where the Xstrahl booth showcased the Xstrahl 100, a mobile superficial radiation therapy (Grenz Ray) system used in the treatment of dermatological disorders including some skin cancers.

The team were encouraged to see an increase in the number of attendees expressing interest in superficial radiation therapy as an essential modality for treating non-melanoma skin cancer. Superficial radiation treatment offers excellent cosmetic results and is considerably less invasive than other treatments. US physicists stopping by the booth to chat with team members indicated the Xstrahl 150's additional energy potential is advantageous because it allows a better margin for treating squamous cell carcinoma.

This year's event saw the inaugeral reveal of the new Xstrahl SARRP3—the only image-guided micro irradiator capable of dose planning and delivering both planar and non-coplanar arc treatments. Using multi-media, the Xstrahl team demonstrated how efficiently the SARRP quickly images and delivers the dose to an anatomical target with pinpoint accuracy, thus enabling the concept of patient specific adaption of radiation therapy to be explored within the research environment. Imaging is a key biomarker in radiation therapy and the SARRP is capable of the potential to interface molecular imaging with tumour specific treatment plans

The SARRP physics user group meeting was held during the conference and was very well attended, with over 20 physicists representing the US installed base. The physicists were impressed by the latest developments of the dose planning system. Highlights of the meeting were Dr. John Wong's presentation of his group's work on the validation, demonstrating how accurate their algorithm is for in vivo models, and Dana Farber's presentation on their new QA phantom, followed by a general discussion of all physics aspects of the SARRP.

Xstrahl would like to thank Dr. Ross Berbeco from the Dana Farber Cancer Institute for chairing the meeting. All of the SARRP users felt it was a valuable meeting and look forward to the consortium meeting to be held during ASTRO in Boston, MA this coming October.

About Xstrahl

Xstrahl is a leading designer and manufacturer of superficial orthovoltage medical X-Ray systems used in the treatment of cancers and dermatological disorders, as well as a pioneer in the development of advanced X–Ray systems for pre-clinical radiation biology research (Life Sciences).

Xstrahl's headquarters are located in Surrey, England and its subsidiary, Gulmay Medical Inc. is in Suwanee, Georgia (United States). AlderMed is a strategic business partner offer the AlderMed 100 (powered by Xstrahl) to the dermatology market.

AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system

Mobile Skin Cancer Treatment now features Xstrahl Superficial Radiation System

aldermed vanCarson City, NV— February 4th, 2011 – AlderMed™ (www.aldermed.com) announced today it has entered into a three-year exclusive distribution agreement with Gulmay Medical™, manufacturer of the Xstrahl-100 therapy system. AlderMed provides the first mobile service to bring low-dose superficial radiotherapy treatment directly to the point-of-care. Together they strive to bring skin cancer patients a non-surgical, painless and effect treatment for non-melanoma skin cancer at their dermatology and cosmetic surgery office.

Applying the AlderMed SRTeam service model, along with the proprietary mobile x-ray technology of the Xstrahl-100™ system, dermatologists can offer their patients more choices when treating basal cell and squamous cell carcinomas. Not only does AlderMed deliver the treatment, it brings added expertise to the dermatologist by provide its own staff of radiation therapists, including access to consultation with medical physicists and radiation oncologists. When compared to other treatment modalities and surgical options, the Xstrahl-100 delivers high cure rates, low recurrence rates, no scarring and the convenience of treatment at the doctor’s office.

“We are privileged to work with the global leader in X-ray therapy devices,” said Larry Findleton, president at AlderMed. “We believe our service improves the quality of care for the patient. At the same time, increasing the value of the dermatologist’s practice, by bringing a very affordable, mobile non-surgical skin cancer treatment service to their office.”

"We are very impressed with the AlderMed SRTeam approach", says Adrian Treverton, Sales Director of Xstrahl. "Including the oncologist, medical physicist and radiation therapist as part of the treatment approach shares our vision of effective delivery of superficial radiation therapy."

About AlderMed
AlderMed is the first provider of mobile non-surgical skin cancer treatment delivered to the point-of-care at the doctor’s office. The company exclusively uses Gulmay Medical’s Xstrahl-100™ system for cost-effective, non-invasive treatment of non-melanoma skin cancers. AlderMed is headquartered in Carson City, NV. www.aldermed.com.  

About Gulmay Medical
Gulmay has pioneered the design of innovative x-ray generators and controls for over 25 years, with thousands of installations throughout the world. Manufacturing facilities in the U.K. and the U.S, with a worldwide network of distributors and service centers.  Every product in the Gulmay /Xstrahl product line is manufactured to the highest quality and conforms to the strictest of quality assurance programs. www.xstrahl.com

Contact
Drew Wilkens
Marketing
800-692-0490
This email address is being protected from spambots. You need JavaScript enabled to view it.



Contact
Drew Wilkens
Marketing
800-692-0490
This email address is being protected from spambots. You need JavaScript enabled to view it.